Centers for Multiple Chronic Diseases Associated with Health Disparities: Prevention, Treatment, and Management (P50 Clinical Trial Required)

UArizona may submit one application.

The purpose of this initiative is to support regional comprehensive research centers on the prevention, treatment, and management of chronic diseases associated with health disparities.

No applicants.

External Deadline
06/10/2021
Internal Deadline
April 22, 2021

2021 July Data Science Research: Personal Health Libraries for Consumers and Patients (R01 Clinical Trial Optional)

UArizona may submit one application.

The National Library of Medicine seeks applications for novel informatics and data science approaches that can help individuals gather, manage and use data and information about their personal health. A goal of this program is to advance research and application by patients and the research community through broadly sharing the results via publication, and through open source mechanisms for data or resource sharing.

No applicants.

External Deadline
07/31/2021
Internal Deadline
April 28, 2021

How can University personnel safeguard research while traveling abroad?

The research that occurs at the University of Arizona is innovative and often of high value and needs protecting even if it is not subject to export control restrictions. Take steps to protect your information, access to university systems, and report to your department administration any concerns or peculiarities that emerge. Steps to secure your research include:
  • limiting what you take abroad;
  • keeping information in your possession or locked in a secure location;

NIMHD Multiple Chronic Disease Disparities Research Coordinating Center (RCC) (U24 Clinical Trial Not Allowed)

UA may submit one application. NIMHD invites applications from eligible institutions to establish a Research Coordinating Center (RCC) to support NIMHD P50 comprehensive research centers on prevention, treatment, and management of comorbid chronic diseases associated with health disparities authorized in Public Law 116-260, the Consolidated Appropriations Act of 2021.

J. Meiling Wang-Roveda

External Deadline
06/11/2021
Internal Deadline
April 22, 2021

Centers for Multiple Chronic Diseases Associated with Health Disparities: Prevention, Treatment, and Management (P50 Clinical Trial Required)

UArizona may submit one application. The purpose of this initiative is to support regional comprehensive research centers on the prevention, treatment, and management of chronic diseases associated with health disparities.

No applicants.

External Deadline
06/10/2021
Internal Deadline
April 22, 2021

What is an IDE?

An investigational device exemption (IDE) is an approval that allows a medical device to be used in a clinical research study that involves human subjects or human specimens. The term “exemption” as it pertains to IDEs, means that the device is exempt from the laws that prohibit unapproved products to move in interstate commerce.

An approved IDE means that the IRB (and FDA for SR devices) has approved the sponsor’s study application and all regulatory requirements are met.

IDEs cover studies that: